News

Deal Announcements

Combinent BioMedical Lands Venture Capital Debt

Thursday, January 5, 2012 5:38:00 AM PDT | VentureDeal Staff
   Lexington, Massachusetts  --  Pharmaceutical company Combinent BioMedical Systems has received $750,000 in new venture capital debt, according to an SEC regulatory filing.

Combinent is developing drug combinations using existing pharmaceutical products combined with its proprietary transvaginal drug delivery system.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Combinent is backed by a syndicate of venture capital and strategic investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1